Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 11/2016

01-11-2016 | Epilepsy (CW Bazil, Section Editor)

Treatment of Epilepsy in the Elderly

Authors: Paul V. Motika, David C. Spencer

Published in: Current Neurology and Neuroscience Reports | Issue 11/2016

Login to get access

Abstract

The treatment of epilepsy in older individuals is an increasingly important topic in neurology and an area that all treating neurologists should have familiarity with. As the population ages, the number of patients over 65 who present with new-onset epilepsy will increase, as will the complexity of their comorbid medical and neurological disorders. In older patients, seizures are often unwitnessed, or present with atypical symptoms, making the diagnosis more challenging. Additionally, there are relatively limited data to guide the use of anti-epileptic medications and other treatments in this patient population. Elderly patients may experience increased side effects from anti-epileptic drugs compared with younger patients and in general, are likely to have a narrower therapeutic window and greater degree of individual variation with respect to side effects. Familiarity with anti-epileptic medication dosing and titration schedules, possible adverse effects, and potential pharmacokinetic and drug interactions can be helpful when considering treatment options and may increase the likelihood of success.
Literature
1.
2.
Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet. 1998;352(9145):1970–3.CrossRefPubMed
3.
de la Court A, Breteler MM, Meinardi H, Hauser WA, Hofman A. Prevalence of epilepsy in the elderly: the Rotterdam Study. Epilepsia. 1996;37(2):141–7.CrossRefPubMed
4.
Christensen J, Vestergaard M, Pedersen MG, Pedersen CB, Olsen J, Sidenius P. Incidence and prevalence of epilepsy in Denmark. Epilepsy Res. 2007;76(1):60–5.CrossRefPubMed
5.
Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34(3):453–68.CrossRefPubMed
6.
7.
Pryor FM, Ramsay RE, Rowan AJ. Epilepsy in older adults: update from VA Cooperative Study #428. Epilepsia. 2002;43(Supplement 7):165–6.
8.
Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology. 2004;62(5 Suppl 2):S24–9.CrossRefPubMed
9.
Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005;64(11):1868–73.CrossRefPubMed
10.
Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res. 1999;37(1):81–7.CrossRefPubMed
11.
Saetre E, Perucca E, Isojarvi J, Gjerstad L, Group LAMS. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia. 2007;48(7):1292–302.CrossRefPubMed
12.•
Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kalviainen R, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54(3):551–63. This paper is a critical review of the published data regarding efficacy of medications to treat new onset seizures. Relevant studies and the defined levels of evidence are described, focusing on recent additions to the literature since the prior iteration in 2006. CrossRefPubMed
13.
Kutluay E, McCague K, D’Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4(2):175–80.CrossRefPubMed
14.
Trinka E, Giorgi L, Patten A, Segieth J. Safety and tolerability of zonisamide in elderly patients with epilepsy. Acta Neurol Scand. 2013;128(6):422–8.CrossRefPubMed
15.
Werhahn KJ, Klimpe S, Balkaya S, Trinka E, Kramer G. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study. Seizure. 2011;20(4):305–11.CrossRefPubMed
16.
Ferrendelli JA, French J, Leppik I, Morrell MJ, Herbeuval A, Han J, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav. 2003;4(6):702–9.CrossRefPubMed
17.
Kutlu G, Gomceli YB, Unal Y, Inan LE. Levetiracetam monotherapy for late poststroke seizures in the elderly. Epilepsy Behav. 2008;13(3):542–4.CrossRefPubMed
18.•
Werhahn KJ, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M, et al. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015;56(3):450–9. This paper represents one of the few RCTs involving treatment comparisons specifically in the elderly population. It is of particular interest given the inclusion of newer generation anti-seizure medications. CrossRefPubMed
19.
Schmidt D. Drug treatment of epilepsy: options and limitations. Epilepsy Behav. 2009;15(1):56–65.CrossRefPubMed
20.
21.
Beerhorst K, van der Kruijs SJ, Verschuure P, Tan IY, Aldenkamp AP. Bone disease during chronic antiepileptic drug therapy: general versus specific risk factors. J Neurol Sci. 2013;331(1-2):19–25.CrossRefPubMed
22.
Petty SJ, Paton LM, O’Brien TJ, Makovey J, Erbas B, Sambrook P, et al. Effect of antiepileptic medication on bone mineral measures. Neurology. 2005;65(9):1358–65.CrossRefPubMed
23.
Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001;57(3):445–9.CrossRefPubMed
24.
Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004;45(11):1330–7.CrossRefPubMed
25.
Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, et al. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy—antiepileptic drug and osteoporosis prevention trial. Epilepsia. 2013;54(11):1997–2004.CrossRefPubMed
26.
Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan GH. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology. 2006;67(11):2005–14.CrossRefPubMed
27.
Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59(1):35–41.CrossRefPubMed
28.
Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72(2):184–91.CrossRefPubMed
29.
30.
McAuley JW, Passen N, Prusa C, Dixon J, Cotterman-Hart S, Shneker BF. An evaluation of the impact of memory and mood on antiepileptic drug adherence. Epilepsy Behav. 2015;43:61–5.CrossRefPubMed
31.
Hamid H, Blackmon K, Cong X, Dziura J, Atlas LY, Vickrey BG, et al. Mood, anxiety, and incomplete seizure control affect quality of life after epilepsy surgery. Neurology. 2014;82(10):887–94.CrossRefPubMedPubMedCentral
32.
Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5(5):399–405.CrossRefPubMed
33.
Jones JE, Hermann BP, Woodard JL, Barry JJ, Gilliam F, Kanner AM, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia. 2005;46(5):731–5.CrossRefPubMed
34.
Mula M, Iudice A, La Neve A, Mazza M, Mazza S, Cantello R, et al. Validation of the Hamilton Rating Scale for Depression in adults with epilepsy. Epilepsy Behav. 2014;41:122–5.CrossRefPubMed
35.
Boling W, Andermann F, Reutens D, Dubeau F, Caporicci L, Olivier A. Surgery for temporal lobe epilepsy in older patients. J Neurosurg. 2001;95(2):242–8.CrossRefPubMed
36.
Grivas A, Schramm J, Kral T, von Lehe M, Helmstaedter C, Elger CE, et al. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia. 2006;47(8):1364–72.CrossRefPubMed
37.
Murphy M, Smith PD, Wood M, Bowden S, O’Brien TJ, Bulluss KJ, et al. Surgery for temporal lobe epilepsy associated with mesial temporal sclerosis in the older patient: a long-term follow-up. Epilepsia. 2010;51(6):1024–9.CrossRefPubMed
38.
Sirven JI, Malamut BL, O’Connor MJ, Sperling MR. Temporal lobectomy outcome in older versus younger adults. Neurology. 2000;54(11):2166–70.CrossRefPubMed
39.
Elliott RE, Morsi A, Kalhorn SP, Marcus J, Sellin J, Kang M, et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav. 2011;20(1):57–63.CrossRefPubMed
40.
Sirven JI, Sperling M, Naritoku D, Schachter S, Labar D, Holmes M, et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology. 2000;54(5):1179–82.CrossRefPubMed
Metadata
Title
Treatment of Epilepsy in the Elderly
Authors
Paul V. Motika
David C. Spencer
Publication date
01-11-2016
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 11/2016
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-016-0696-8

Other articles of this Issue 11/2016

Current Neurology and Neuroscience Reports 11/2016 Go to the issue

Demyelinating Disorders (DN Bourdette and M Cameron, Section Editors)

Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation

Epilepsy (CW Bazil, Section Editor)

Toward a Mechanistic Understanding of Epileptic Networks

Headache (RB Halker, Section Editor)

Post-Concussive Syndrome: a Focus on Post-Traumatic Headache and Related Cognitive, Psychiatric, and Sleep Issues

Critical Care (SA Mayer, Section Editor)

Communication, Leadership, and Decision-Making in the Neuro-ICU

Epilepsy (CW Bazil, Section Editor)

Prevention of Epilepsy: Issues and Innovations

Headache (RB Halker, Section Editor)

Headaches: a Review of the Role of Dietary Factors